Cargando…

Bioresorbable scaffold implantation in STEMI patients: 5 years imaging subanalysis of PRAGUE-19 study

BACKGROUND: Bioresorbable scaffold (BRS) Absorb™ clinical use has been stopped due to higher rate of device thrombosis. Scaffold struts persist longer than 2 years in the vessel wall. Second generation devices are being developed. This study evaluates long-term invasive imaging in STEMI patients. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kočka, Viktor, Toušek, Petr, Kozel, Martin, Buono, Andrea, Hajšl, Martin, Lisa, Libor, Buděšínský, Tomáš, Malý, Martin, Widimský, Petr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993315/ https://www.ncbi.nlm.nih.gov/pubmed/32000796 http://dx.doi.org/10.1186/s12967-020-02230-1

Ejemplares similares

Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study ‘Prague 19’
por: Kočka, Viktor, et al.
Publicado: (2014)

Takotsubo Cardiomyopathy: One More Angiographic Evidence of Microvascular Dysfunction
por: Loffi, Marco, et al.
Publicado: (2018)

Comparison of a Bioresorbable, Magnesium-Based Sirolimus-Eluting Stent with a Permanent, Everolimus-Eluting Metallic Stent for Treating Patients with Acute Coronary Syndrome: the PRAGUE-22 Study
por: Toušek, Petr, et al.
Publicado: (2021)

Might simplification of transcatheter aortic valve implantation reduce the burden on hospital resources?
por: Kratochvílová, Lenka, et al.
Publicado: (2022)

Pharmacodynamic Effect of Clopidogrel in Patients Undergoing Transcatheter Aortic Valve Implantation
por: Tousek, Petr, et al.
Publicado: (2013)

Relationship between TRAIL and Left Ventricular Ejection Fraction in Patients with ST-Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention
por: Teringova, Elena, et al.
Publicado: (2018)

Nurse-led sedation for transfemoral transcatheter aortic valve implantation seems safe for a selected patient population
por: Kočka, Viktor, et al.
Publicado: (2022)

Current cardiovascular research at the Charles University: the ‘PRAGUE’ trials and beyond
por: Widimsky, Petr, et al.
Publicado: (2020)

Patient characteristics, treatment strategy, outcomes, and hospital costs of acute coronary syndrome: 3 years of data from a large high-volume centre in Central Europe
por: Toušek, Petr, et al.
Publicado: (2022)

Design and Rationale of the PRAGUE‐12 Trial: A Large, Prospective, Randomized, Multicenter Trial That Compares Cardiac Surgery With Left Atrial Surgical Ablation With Cardiac Surgery Without Ablation in Patients With Coronary and/or Valvular Heart Disease Plus Atrial Fibrillation
por: Straka, Zbyněk, et al.
Publicado: (2012)

Modified Strategies for Invasive Management of Acute Coronary Syndrome during the COVID-19 Pandemic
por: Toušek, Petr, et al.
Publicado: (2020)

Clopidogrel pre-treatment in stable angina: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8
por: Widimský, Petr, et al.
Publicado: (2008)

The importance of interdisciplinary research
por: Widimsky, Petr, et al.
Publicado: (2023)

Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study(†)
por: Budera, Petr, et al.
Publicado: (2012)

Long-term follow-up in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention
por: Klancik, Viktor, et al.
Publicado: (2022)

Pre-hospital delay, clinical characteristics, angiographic findings, and in-hospital mortality in young and middle-aged adults with acute coronary syndrome: a single-centre registry analysis
por: Bauer, Dávid, et al.
Publicado: (2023)

Antithrombotic therapy of patients with atrial fibrillation discharged after major non-cardiac surgery. 1-year follow-up. Sub-analysis of PRAGUE 14 study
por: Ondrakova, Martina, et al.
Publicado: (2017)

Delayed neointimal healing pattern after bioresorbable scaffold implantation
por: Ochijewicz, D., et al.
Publicado: (2018)

Predictors allowing early discharge after interventional treatment of acute coronary syndrome patients
por: Bauer, Dávid, et al.
Publicado: (2022)

Invasive Hemodynamic Assessment of Cardiac Output State after MitraClip Therapy in Nonanaesthetized Patients with Functional Mitral Regurgitation
por: Bednar, Frantisek, et al.
Publicado: (2016)

Prognostic Value of TNF-Related Apoptosis Inducing Ligand (TRAIL) in Acute Coronary Syndrome Patients
por: Osmancik, Pavel, et al.
Publicado: (2013)

The contribution of the WLCG Tier-2 site in Prague to the global WLCG operations
por: Adamova, Dagmar, et al.
Publicado: (2021)

Intravascular haemolysis after transcatheter aortic valve implantation with self-expandable prosthesis: incidence, severity, and impact on long-term mortality
por: Širáková, Andrea, et al.
Publicado: (2020)

Asymptotic Statistics : Proceedings of the 5th Prague Symposium
por: Mandl, Petr, et al.
Publicado: (1994)

Triggers, characteristics, and hospital outcome of patients with Takotsubo syndrome: 10 years experience in a large university hospital centre
por: Polednikova, Karolina, et al.
Publicado: (2023)

Bioresorbable scaffolds: everything resolved?
por: Appelman, Yolande
Publicado: (2015)

Bioresorbable Scaffolds for Atheroregression: Understanding of Transient Scaffolding
por: N. Kharlamov, M.D., Alexander
Publicado: (2016)

First-in-man Implantation of the XINSORB Bioresorbable Sirolimus-eluting Scaffold in China
por: Chen, Jia-Hui, et al.
Publicado: (2015)

Impact of PSP Technique on Clinical Outcomes Following Bioresorbable Scaffolds Implantation
por: Ortega-Paz, Luis, et al.
Publicado: (2018)

Multimodality intravascular imaging of bioresorbable vascular scaffolds implanted in vein grafts
por: Roleder, Tomasz, et al.
Publicado: (2019)

Dissections after bioresorbable vascular scaffold implantation in the POLAR ACS Registry
por: Zasada, Wojciech, et al.
Publicado: (2022)

Neoatherosclerosis development following bioresorbable vascular scaffold implantation in diabetic and non-diabetic swine
por: van Ditzhuijzen, Nienke S., et al.
Publicado: (2017)

Prague
Publicado: (1998)

Prague /
Publicado: (1979)

Prague /
por: Seiland, Alfred, 1952-
Publicado: (1994)

Prague /
por: Grenier, Roger 1919-2017
Publicado: (1987)

Fully automated measurement of aortic root anatomy using Philips HeartNavigator computed tomography software: fast, accurate, or both?
por: Kočka, Viktor, et al.
Publicado: (2022)

Bioresorbable scaffolds for percutaneous coronary interventions
por: Gogas, Bill D.
Publicado: (2014)

Bioresorbable Polymeric Scaffold in Cardiovascular Applications
por: Toong, Daniel Wee Yee, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0bq02acvs87e0hpci44nc5o378